Clinical Trials

RECRUITING
Olaparib in Subjects With Advanced Pancreatic Acinar Cell Carcinoma
Background: Pancreatic Acinar Cell Carcinoma (PACC) is a rare pancreatic tumor. People with PACC usually present with advanced disease, and their pro...
Conditions:
Pancreatic Acinar Cell Carcinoma
Locations:
📍 Bethesda, Maryland, United States
RECRUITING
Image-guided Focal Brachytherapy Utilizing Combined 18F-DCFPyl PET/CT
The Principal Investigator's (PI) working hypothesis is that the PI can utilize the high predictive value of 18F-DCFPyl PSMA to identify clinically si...
Conditions:
Prostate Cancer
Locations:
📍 Baltimore, Maryland, United States
RECRUITING
A Multi-Center, Prospective, Observational Study of Patients Being Treated With ORGOVYX
This is a multi-center, prospective, observational study of patients being treated with ORGOVYX. The goal of this study is to generate real-world evid...
Conditions:
Prostate Cancer
Locations:
📍 Homewood, Alabama, United States
📍 Mobile, Alabama, United States
📍 Phoenix, Arizona, United States
📍 Tucson, Arizona, United States
59 more locations available...
RECRUITING
A Study of CLN-619 Alone and in Combination With Pembrolizumab in Advanced Solid Tumors
CLN-619-001 is a Phase 1, open-label, multi-center study of CLN-619 alone and in combination with pembrolizumab in patients with advanced solid tumors...
Conditions:
Advanced Solid Tumor
Locations:
📍 Duarte, California, United States
📍 Irvine, California, United States
📍 Sarasota, Florida, United States
📍 Boston, Massachusetts, United States
18 more locations available...
RECRUITING
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
The purpose of this study is to compare sacituzumab tirumotecan as a single agent, and in combination with pembrolizumab, versus Treatment of Physicia...
Conditions:
Breast Neoplasms
Locations:
📍 Baltimore, Maryland, United States
📍 Nyack, New York, United States
📍 Rosario, Santa Fe, Argentina
📍 Cordoba, Argentina
25 more locations available...
NOT_YET_RECRUITING
Immune Cell Therapy (CAR-T) for the Treatment of Patients With HIV and B-Cell Non-Hodgkin Lymphoma
This phase I trial evaluates the side effects and usefulness of axicabtagene clioleucel (a CAR-T therapy) and find out what effect, if any, it has on ...
Conditions:
AIDS-Related Diffuse Large B-cell Lymphoma AIDS-Related Non-Hodgkin Lymphoma HIV Infection Recurrent Diffuse Large B-Cell Lymphoma
11 more conditions available...
Locations:
📍 New York, New York, United States
RECRUITING
Study of Futibatinib in Patients With Advanced Cholangiocarcinoma With FGFR2 Fusion or Rearrangement
This is an open-label, multinational, randomized Phase 2 study confirming the clinical benefit of 20 mg futibatinib and evaluating the safety and effi...
Conditions:
Advanced Cholangiocarcinoma FGFR2 Fusions Gene Rearrangement
Locations:
📍 La Jolla, California, United States
📍 Detroit, Michigan, United States
📍 Canton, Ohio, United States
📍 Abilene, Texas, United States
47 more locations available...
RECRUITING
Comparing Proton Therapy to Photon Radiation Therapy for Esophageal Cancer
This trial studies how well proton beam radiation therapy compared with intensity modulated photon radiotherapy works in treating patients with stage ...
Conditions:
Clinical Stage I Esophageal Adenocarcinoma AJCC v8 Clinical Stage I Esophageal Squamous Cell Carcinoma AJCC v8 Clinical Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8 Clinical Stage II Esophageal Adenocarcinoma AJCC v8
63 more conditions available...
Locations:
📍 Phoenix, Arizona, United States
📍 Scottsdale, Arizona, United States
📍 Coral Gables, Florida, United States
📍 Deerfield Beach, Florida, United States
82 more locations available...
RECRUITING
GRETeL: Tumor Response to Standard Radiotherapy and TMZ Patients With GBM
The purpose of this study is to better define longitudinal genomic alterations in patients with glioblastoma (GBM), and to determine if plasma circula...
Conditions:
Glioblastoma Glioma, Malignant
Locations:
📍 Durham, North Carolina, United States
NOT_YET_RECRUITING
Glofitamab Plus Ibrutinib With Obinutuzumab for the Treatment of Patients With Mantle Cell Lymphoma
This phase IB/II trial tests the safety, side effects and effectiveness of glofitamab plus ibrutinib with obinutuzumab for the treatment of patients w...
Conditions:
Mantle Cell Lymphoma
Locations:
📍 Portland, Oregon, United States
RECRUITING
Radiation Dose Study for Relapsed/Refractory Hodgkin/Non-Hodgkin Lymphoma
This study focuses on using shortened courses of radiation for participants with relapsed/refractory Hodgkin/Non-Hodgkin lymphoma. Treatment radiation...
Conditions:
Non-hodgkin Lymphoma Hodgkin Lymphoma Lymphoma
Locations:
📍 Chicago, Illinois, United States
NOT_YET_RECRUITING
Pilot Trial of Intravenous Iron in Combination With Standard of Care Immunotherapy in Melanoma
Anemia is a common complication among cancer patients and is negatively associated with overall prognosis and therapeutic outcomes. The purpose of thi...
Conditions:
Anemia, Iron Deficiency Melanoma
Locations:
📍 Indianapolis, Indiana, United States
RECRUITING
ASk Questions in GYnecologic Oncology (ASQ-GYO)
The goal of this clinical trial is to determine the effectiveness of the ASk Questions in GYnecologic Oncology question prompt list (ASQ-GYO QPL) at i...
Conditions:
Ovarian Cancer Endometrial Cancer Cervical Cancer Vulvar Cancer
2 more conditions available...
Locations:
📍 Detroit, Michigan, United States
RECRUITING
REJOIN Trial for Older Breast Cancer Survivors
The purpose of this pilot intervention study is to test the effectiveness of a self-management approach (combining education- and exercise-based strat...
Conditions:
Breast Cancer Female
Locations:
📍 Winston-Salem, North Carolina, United States
NOT_YET_RECRUITING
A Phase I Study Investigating the Combination of the Ziftomenib, Venetoclax and Azacitidine in Pediatric Relapsed and Refractory Acute Leukemias
To find the highest safe dose of ziftomenib that can be combined with venetoclax and azacitidine in pediatric participants with acute leukemia that ha...
Conditions:
Refractory Acute Leukemia Pediatric Relapsed
Locations:
📍 Houston, Texas, United States

Total Trials: 1 - 15 of 6772